Zhiyong Zhang Selected Research

Myocardial Infarction

10/2022	Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow.
1/2021	Association of genetic defects in the apelin-AGTRL1 system with myocardial infarction risk in Han Chinese.
1/2019	Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
6/2018	Susceptibility of multiple polymorphisms in ADIPOQ, ADIPOR1 and ADIPOR2 genes to myocardial infarction in Han Chinese.
11/2017	Predictive Nomogram of RAGE Genetic Polymorphisms and Metabolic Risk Factors for Myocardial Infarction Risk in a Han Chinese Population.
8/2017	The association of eight potentially functional polymorphisms in five adrenergic receptor-encoding genes with myocardial infarction risk in Han Chinese.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyong Zhang Research Topics

Disease

90	Neoplasms (Cancer) 05/2024 - 01/2003
22	Infections 05/2024 - 01/2011
22	Inflammation (Inflammations) 04/2024 - 08/2008
21	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 10/2007
18	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2007
17	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 03/2007
12	Hypoxia (Hypoxemia) 01/2021 - 03/2008
10	Colonic Neoplasms (Colon Cancer) 02/2024 - 12/2011
9	Lung Neoplasms (Lung Cancer) 06/2023 - 02/2004
9	Heart Failure 04/2023 - 02/2007
9	Leukemia 01/2023 - 06/2013
9	Carcinogenesis 12/2022 - 01/2007
8	Stomach Neoplasms (Stomach Cancer) 11/2023 - 01/2011
7	Cognitive Dysfunction 06/2023 - 01/2020
7	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2019
6	Wounds and Injuries (Trauma) 02/2024 - 01/2011
6	Goldenhar Syndrome (Hemifacial Microsomia) 03/2023 - 05/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 08/2012
6	Myocardial Infarction 10/2022 - 08/2017
6	Human Influenza (Influenza) 01/2015 - 01/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 07/2009
5	Breast Neoplasms (Breast Cancer) 09/2023 - 11/2021
5	Hypertension (High Blood Pressure) 02/2023 - 03/2014
5	Ischemia 01/2023 - 09/2006
5	Glioma (Gliomas) 01/2022 - 06/2006
5	Atherosclerosis 12/2021 - 02/2011
5	Pneumonia (Pneumonitis) 10/2020 - 06/2013
4	Fever (Fevers) 01/2024 - 10/2020
4	Type 2 Diabetes Mellitus (MODY) 09/2023 - 09/2015
4	Abdominal Obesity 07/2023 - 01/2021
4	Obesity 07/2023 - 01/2021
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2007
4	Potassium Deficiency 01/2021 - 02/2016
4	Melanoma (Melanoma, Malignant) 01/2021 - 07/2009
4	Congenital Abnormalities (Deformity) 05/2011 - 07/2002
3	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 01/2016
3	Pain (Aches) 02/2024 - 01/2020
3	Osteoporosis 12/2023 - 01/2018
3	Primary Immunodeficiency Diseases 01/2023 - 11/2021
3	Reperfusion Injury 01/2023 - 02/2016

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2007
24	Biomarkers (Surrogate Marker)IBA 02/2024 - 03/2008
19	MicroRNAs (MicroRNA)IBA 01/2023 - 12/2011
10	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2015
9	CytokinesIBA 01/2024 - 01/2014
9	Messenger RNA (mRNA)IBA 08/2021 - 02/2004
8	Therapeutic UsesIBA 03/2022 - 01/2017
8	LipidsIBA 01/2021 - 09/2006
7	Circular RNAIBA 02/2024 - 01/2018
6	MetalsIBA 12/2023 - 10/2015
6	Phosphotransferases (Kinase)IBA 01/2021 - 06/2006
6	AutoantibodiesIBA 01/2018 - 06/2008
5	Heavy MetalsIBA 04/2024 - 01/2022
5	Contrast MediaIBA 12/2023 - 01/2017
5	Apolipoproteins E (ApoE)IBA 01/2023 - 02/2011
5	Small Interfering RNA (siRNA)IBA 01/2019 - 06/2006
5	Cholinergic ReceptorsIBA 01/2018 - 06/2008
5	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 05/2010
4	AntigensIBA 05/2024 - 01/2014
4	Immunoglobulin G (IgG)IBA 05/2024 - 01/2011
4	AntibodiesIBA 05/2024 - 01/2011
4	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 08/2017
4	ManganeseIBA 12/2023 - 09/2006
4	Carbon Nanotubes (Carbon Nanotube)IBA 09/2023 - 11/2021
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2023 - 12/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 04/2014
4	VaccinesIBA 01/2023 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 09/2009
4	SolutionsIBA 01/2022 - 01/2019
4	Peptides (Polypeptides)IBA 12/2021 - 01/2011
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 04/2009
4	SaltsIBA 01/2021 - 01/2011
4	Indicators and Reagents (Reagents)IBA 10/2020 - 03/2017
4	Dental Implants (Dental Implant)IBA 01/2017 - 04/2014
4	ProteomeIBA 02/2016 - 05/2010
3	Immunoglobulins (Immunoglobulin)IBA 05/2024 - 01/2022
3	Glutathione (Reduced Glutathione)IBA 05/2024 - 01/2020
3	Pyruvic Acid (Pyruvate)IBA 05/2024 - 12/2019
3	LigandsIBA 02/2024 - 06/2014
3	CadmiumIBA 12/2023 - 01/2022
3	IronIBA 12/2023 - 09/2006
3	CalciumIBA 12/2023 - 09/2006
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2023 - 01/2018
3	Ethanol (Ethyl Alcohol)IBA 07/2023 - 01/2011
3	Toll-Like Receptor 4IBA 01/2023 - 01/2016
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 01/2019
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 01/2020
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2022 - 01/2015
3	Long Noncoding RNAIBA 10/2022 - 01/2018

Therapy/Procedure

40	Therapeutics 05/2024 - 02/2004
6	Immunotherapy 02/2024 - 01/2021
6	Distraction Osteogenesis 03/2023 - 09/2009
6	Drug Therapy (Chemotherapy) 01/2023 - 10/2011
5	Precision Medicine 11/2023 - 01/2017
5	Osteotomy 09/2017 - 07/2002
5	Prostheses and Implants (Prosthesis) 12/2016 - 10/2006
4	Radiotherapy 01/2022 - 12/2016
4	Stents 01/2020 - 08/2008
3	Photochemotherapy (Photodynamic Therapy) 11/2023 - 01/2020
3	Patient Readmission 04/2023 - 01/2019